Clinical Trial Update: A Study of Glucocorticoid Use to Evaluate Systematic Methylprednisolone Reduction in Patients With Rheumatoid Arthritis on Background RoActemra/Actemra (Tocilizumab) (ACT-ALONE) [Phase 4]

View source ↗

Summary

Phase 4 trial ACT-ALONE evaluated reducing systemic methylprednisolone in rheumatoid arthritis patients receiving background tocilizumab (Actemra); results were…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Actemra (tocilizumab)
• METHYLPREDNISOLONE (methylprednisolone)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED | Results posted: 2015-01-19